Valion Bio, Inc.
For the period ended Jun 30, 2026. Filed Aug 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 14, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
Our condensed consolidated financial statements included in this Quarterly Report on Form 10‑Q are as follows:
| Condensed Consolidated Balance Sheets as of June 30, 2026 (unaudited) and December 31, 2025 | 2 |
|---|---|
| Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2026 and 2025 (unaudited) | 3 |
| Condensed Consolidated Statements of Stockholders’ Equity for the three and six months ended June 30, 2026 and 2025 (unaudited) | 4 |
| Condensed Consolidated Statements of Cash Flow for the six months ended June 30, 2026 and 2025 (unaudited) | 5 |
| Notes to Condensed Consolidated Financial Statements (unaudited) | 6 |
This Quarterly Report on Form 10‑Q (this “Quarterly Report”) for the quarter ended June 30, 2026, should be read in conjunction with Valion Bio, Inc.’s Annual Report on Form 10‑K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (the “SEC”) on March 30, 2026.
The accompanying condensed consolidated financial statements and footnotes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10‑Q. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended June 30, 2026 are not necessarily indicative of the results that can be expected for the full year.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.